Synthesis and biological evaluation of benzothiazin-4-ones: a possible new class of acetylcholinesterase inhibitors

被引:10
作者
Berwaldt, Gabriele A. [1 ]
Gouvea, Daniela P. [1 ]
da Silva, Daniel S. [1 ,2 ]
das Neves, Adriana M. [1 ]
Soares, Mayara S. P. [2 ]
Azambuja, Juliana H. [2 ]
Siqueira, Geonir M. [1 ]
Spanevello, Roselia M. [2 ]
Cunico, Wilson [1 ]
机构
[1] Univ Fed Pelotas, Lab Quim Aplicada Bioat, Ctr Ciencias Quim Farmaceut & Alimentos, Predio 32,Lab 410,Campus Univ S-N, BR-96160000 Capao De Leao, RS, Brazil
[2] Univ Fed Pelotas, Lab Neuroquim Inflamacao & Canc, Ctr Ciencias Quim Farmaceut & Alimentos, Predio 29,Sala 303,Campus Univ S-N, BR-96160000 Capao De Leao, RS, Brazil
关键词
Benzothiazinone; propylpiperidine; acetylcholinesterase; fibroblast cells; DERIVATIVES; DOCKING; DESIGN;
D O I
10.1080/14756366.2018.1543286
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A series of nineteen benzothiazin-4-ones from N-(3-aminopropyl) piperidine, 4-(2-aminoethyl)morpholine or 1-(2-aminoethyl)piperidine, aliphatic or aromatic aldehyde and thiosalicylic acid, were synthesized in good yields by multicomponent one-pot reactions. The solvent was toluene and this efficient procedure afforded the desired heterocycles in 5 h. Identification and characterization were achieved by NMR and GC-MS techniques. In vitro AChE activities of all compounds were evaluated in cerebral cortex and hippocampus of rats and in general, the results in cortex were more promising than hippocampus. The benzothiazinone 5Bd showed the best AChE inhibition activity IC50 8.48 mu M (cortex) and IC50 39.80 mu M (hippocampus). The cytotoxicity of seven compounds in MCR-5 human fibroblast cell by SRB test in 24 h were evaluated and 5Bd suggest preliminary safety, showing no cytotoxicity at 100 mu M. Finally, these important findings could be a starting point for the development of new AChE inhibitors agents and will provide the basis for new studies.
引用
收藏
页码:197 / 203
页数:7
相关论文
共 23 条
[1]   A review on cholinesterase inhibitors for Alzheimer's disease [J].
Anand, Preet ;
Singh, Baldev .
ARCHIVES OF PHARMACAL RESEARCH, 2013, 36 (04) :375-399
[2]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&
[3]   Facile synthesis of oxo-/thioxopyrimidines and tetrazoles C-C linked to sugars as novel non-toxic antioxidant acetylcholinesterase inhibitors [J].
Figueiredo, J. A. ;
Ismael, M. I. ;
Pinheiro, J. M. ;
Silva, A. M. S. ;
Justino, J. ;
Silva, F. V. M. ;
Goulart, M. ;
Mira, D. ;
Araujo, M. E. M. ;
Campoy, R. ;
Rauter, A. P. .
CARBOHYDRATE RESEARCH, 2012, 347 (01) :47-54
[4]   A century of Alzheimer's disease [J].
Goedert, Michel ;
Spillantini, Maria Grazia .
SCIENCE, 2006, 314 (5800) :777-781
[5]   2-Aryl-3-(2-morpholinoethyl)thiazolidin-4-ones: Synthesis, anti-inflammatory in vivo, cytotoxicity in vitro and molecular docking studies [J].
Gouvea, Daniela Pires ;
Vasconcellos, Flavia Aleixo ;
Berwaldt, Gabriele dos Anjos ;
Pinto Seixas Neto, Amilton Clair ;
Fischer, Gerferson ;
Sakata, Renata Parruca ;
Almeida, Wanda Pereira ;
Cunico, Wilson .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 118 :259-265
[6]   Synthesis, antitumor activity and molecular docking study of novel Sulfonamide-Schiff's bases, thiazolidinones, benzothiazinones and their C-nucleoside derivatives [J].
Kamel, Mohsen M. ;
Ali, Hamed I. ;
Anwar, Manal M. ;
Mohamed, Neama A. ;
Soliman, AbdelMohsen M. .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2010, 45 (02) :572-580
[7]   Substrate scope in the direct imine acylation of ortho-substituted benzoic acid derivatives: the total synthesis (±)-cavidine [J].
Kitsiou, Christiana ;
Unsworth, William P. ;
Coulthard, Graeme ;
Taylor, Richard J. K. .
TETRAHEDRON, 2014, 70 (40) :7172-7180
[8]   Discovery of non-glucoside SGLT2 inhibitors [J].
Li, An-Rong ;
Zhang, Jian ;
Greenberg, Joanne ;
Lee, TaeWeon ;
Liu, Jiwen .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (08) :2472-2475
[9]  
Maheshwari M., 2015, ASIAN J PHARM CLIN R, V8, P41
[10]  
Martocchia A., 2008, The Open Neuropsychopharmacology Journal, V1, P19, DOI DOI 10.2174/1876523800801010019